FDA Approved: NADOLOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Nadolol submitted by Aurobindo Pharma Limited under the ANDA, approving updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Esophageal Variceal Bleeding
• Hypertension

Drugs mentioned

• Nadolol (Nadolol)

Snippet

SUPPL AP for NADOLOL (NADOLOL)